These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26817233)

  • 1. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
    Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
    J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
    Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
    [No Abstract]   [Full Text] [Related]  

  • 3. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
    Tribuddharat C; Moore RA; Baker P; Woods DE
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2082-7. PubMed ID: 12821450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
    Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
    ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.
    Chirakul S; Norris MH; Pagdepanichkit S; Somprasong N; Randall LB; Shirley JF; Borlee BR; Lomovskaya O; Tuanyok A; Schweizer HP
    Sci Rep; 2018 Jul; 8(1):10652. PubMed ID: 30006637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
    Chirakul S; Somprasong N; Norris MH; Wuthiekanun V; Chantratita N; Tuanyok A; Schweizer HP
    Int J Antimicrob Agents; 2019 May; 53(5):582-588. PubMed ID: 30639528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
    Dutta S; Haq S; Hasan MR; Haq JA
    BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of BAL30072 against Burkholderia pseudomallei.
    Mima T; Kvitko BH; Rholl DA; Page MG; Desarbre E; Schweizer HP
    Int J Antimicrob Agents; 2011 Aug; 38(2):157-9. PubMed ID: 21596528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
    Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutation P174L of the penA gene endowing ceftazidime resistance to Burkholderia pseudomallei in China.
    Tian S; Wu X; Liu L; Li A; Li X; Pei H; Wang Y; Dance DAB; Chen H; Xia Q
    Drug Resist Updat; 2024 Sep; 76():101121. PubMed ID: 39018660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
    Maloney S; Engler C; Norton R
    J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
    Karunakaran R; Puthucheary SD
    Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
    Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
    PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.
    Sam IC; See KH; Puthucheary SD
    J Clin Microbiol; 2009 May; 47(5):1556-8. PubMed ID: 19297597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Susceptibility of Western Hemisphere Isolates of
    Bugrysheva JV; Lascols C; McLaughlin HP; Gee JE; Elrod MG; Sue D
    Microb Drug Resist; 2021 Sep; 27(9):1176-1185. PubMed ID: 33570476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Clinical Isolates of
    Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
    Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
    Jenney AW; Lum G; Fisher DA; Currie BJ
    Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam.
    Sribenjalux W; Wonglakorn L; Meesing A
    J Glob Antimicrob Resist; 2022 Mar; 28():8-11. PubMed ID: 34922057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.